{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:06:54Z","timestamp":1790719614684,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health","award":["HD039783"],"award-info":[{"award-number":["HD039783"]}]},{"name":"Canadian Institutes of Health Research CIHR","award":["MOP86489"],"award-info":[{"award-number":["MOP86489"]}]},{"name":"Canadian Institutes of Health Research CIHR","award":["MOP68898"],"award-info":[{"award-number":["MOP68898"]}]},{"name":"Canadian Institutes of Health Research CIHR","award":["MOP79262"],"award-info":[{"award-number":["MOP79262"]}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ebiom.2019.01.042","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T10:53:57Z","timestamp":1548845637000},"page":"655-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18\u202fmonths"],"prefix":"10.1016","volume":"40","author":[{"given":"Cecil M.Y.","family":"Chau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.D.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vann","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne R.","family":"Synnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Carleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E.","family":"Grunau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2019.01.042_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.semperi.2007.07.002","article-title":"Do ventilated neonates require pain management?","volume":"31","author":"Hall","year":"2007","journal-title":"Semin Perinatol"},{"issue":"10","key":"10.1016\/j.ebiom.2019.01.042_bb0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2213-2600(15)00331-8","article-title":"Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study","volume":"3","author":"Carbajal","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.ebiom.2019.01.042_bb0015","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1542\/peds.2004-1398","article-title":"Morphine, hypotension, and adverse outcomes among preterm neonates: who's to blame? Secondary results from the NEOPAIN trial","volume":"115","author":"Hall","year":"2005","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.ebiom.2019.01.042_bb0020","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1001\/jama.290.18.2419","article-title":"Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial","volume":"290","author":"Simons","year":"2003","journal-title":"JAMA"},{"issue":"9422","key":"10.1016\/j.ebiom.2019.01.042_bb0025","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(04)16251-X","article-title":"Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial","volume":"363","author":"Anand","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2019.01.042_bb0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1542\/peds.2005-0441","article-title":"Morphine sedation in ventilated newborns: who are we treating?","volume":"116","author":"Levene","year":"2005","journal-title":"Pediatrics"},{"issue":"Suppl. 2","key":"10.1016\/j.ebiom.2019.01.042_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0196-9781(85)90131-7","article-title":"Modulation of brain development by morphine: effects on central motor systems and behavior","volume":"6","author":"Handelmann","year":"1985","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.ebiom.2019.01.042_bb0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroscience.2007.05.020","article-title":"Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice","volume":"147","author":"Ma","year":"2007","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.ebiom.2019.01.042_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1542\/peds.2003-1150-L","article-title":"Prevalence, stability, and predictors of clinically significant behavior problems in low birth weight children at 3, 5, and 8 years of age","volume":"114","author":"Gray","year":"2004","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ebiom.2019.01.042_bb0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1542\/peds.2008-2816","article-title":"Meta-analysis of neurobehavioral outcomes in very preterm and\/or very low birth weight children","volume":"124","author":"Aarnoudse-Moens","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ebiom.2019.01.042_bb0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.288.6.728","article-title":"Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis","volume":"288","author":"Bhutta","year":"2002","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ebiom.2019.01.042_bb0060","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1001\/jama.289.24.3264","article-title":"Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s","volume":"289","author":"Anderson","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ebiom.2019.01.042_bb0065","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1542\/peds.2004-0932","article-title":"Psychosocial and academic characteristics of extremely low birth weight (< or =800 g) adolescents who are free of major impairment compared with term-born control subjects","volume":"114","author":"Grunau","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ebiom.2019.01.042_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.earlhumdev.2011.01.023","article-title":"Behavior problems of 9-16 year old preterm children: biological, sociodemographic, and intellectual contributions","volume":"87","author":"Loe","year":"2011","journal-title":"Early Hum Dev"},{"issue":"1","key":"10.1016\/j.ebiom.2019.01.042_bb0075","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1542\/peds.2007-3747","article-title":"Shyness and timidity in young adults who were born at extremely low birth weight","volume":"122","author":"Schmidt","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ebiom.2019.01.042_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1542\/peds.2008-2315","article-title":"Functioning at school age of moderately preterm children born at 32 to 36 weeks' gestational age","volume":"124","author":"van Baar","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ebiom.2019.01.042_bb0085","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/j.1532-2149.2013.00431.x","article-title":"Internalizing behaviours in school-age children born very preterm are predicted by neonatal pain and morphine exposure","volume":"18","author":"Ranger","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ebiom.2019.01.042_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpeds.2015.12.024","article-title":"Smaller cerebellar growth and poorer neurodevelopmental outcomes in very preterm infants exposed to neonatal morphine","volume":"172","author":"Zwicker","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.ebiom.2019.01.042_bb0095","first-page":"8(409)","article-title":"Neonatal pain and COMT Val158Met genotype in relation to serotonin transporter (SLC6A4) promoter methylation in very preterm children at school age","author":"Chau","year":"2014","journal-title":"Front Behav Neurosci"},{"issue":"14","key":"10.1016\/j.ebiom.2019.01.042_bb0100","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00003088-200443140-00003","article-title":"Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives","volume":"43","author":"Lotsch","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"13","key":"10.1016\/j.ebiom.2019.01.042_bb0105","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2010.34.3467","article-title":"Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children","volume":"30","author":"Visscher","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.01.042_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpeds.2006.10.053","article-title":"Altered basal cortisol levels at 3, 6, 8 and 18 months in infants born at extremely low gestational age","volume":"150","author":"Grunau","year":"2007","journal-title":"J Pediatr"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2019.01.042_bb0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pain.2009.02.014","article-title":"Neonatal pain, parenting stress and interaction, in relation to cognitive and motor development at 8 and 18 months in preterm infants","volume":"143","author":"Grunau","year":"2009","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.ebiom.2019.01.042_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/mpd.2001.109608","article-title":"SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores","volume":"138","author":"Richardson","year":"2001","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.ebiom.2019.01.042_bb0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.22267","article-title":"Procedural pain and brain development in premature newborns","volume":"71","author":"Brummelte","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2019.01.042_bb0130","series-title":"Manual for ASEBA preschool forms & profiles","author":"Achenbach","year":"2000"},{"issue":"10","key":"10.1016\/j.ebiom.2019.01.042_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076702","article-title":"Neonatal pain-related stress predicts cortical thickness at age 7 years in children born very preterm","volume":"8","author":"Ranger","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2019.01.042_bb0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpeds.2015.04.055","article-title":"Neonatal pain and infection relate to smaller cerebellum in very preterm children at school age","volume":"167","author":"Ranger","year":"2015","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.ebiom.2019.01.042_bb0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.fpc.0000114771.78957.cb","article-title":"Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells","volume":"14","author":"Nagar","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"8","key":"10.1016\/j.ebiom.2019.01.042_bb0150","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/hmg\/ddr619","article-title":"Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer","volume":"21","author":"Tang","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.ebiom.2019.01.042_bb0155","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/aps.2016.157","article-title":"The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants","volume":"38","author":"Yang","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"10.1016\/j.ebiom.2019.01.042_bb0160","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0024-3205(94)00552-4","article-title":"The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex","volume":"54","author":"Bartlett","year":"1994","journal-title":"Life Sci"},{"issue":"17","key":"10.1016\/j.ebiom.2019.01.042_bb0165","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1523\/JNEUROSCI.22-17-07650.2002","article-title":"Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism","volume":"22","author":"Mao","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.ebiom.2019.01.042_bb0170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0304-3959(95)00022-K","article-title":"Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain","volume":"61","author":"Mao","year":"1995","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.ebiom.2019.01.042_bb0175","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abbi.1999.1155","article-title":"Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate","volume":"365","author":"King","year":"1999","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.ebiom.2019.01.042_bb0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"5807","key":"10.1016\/j.ebiom.2019.01.042_bb0185","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1131262","article-title":"Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure","volume":"314","author":"Nackley","year":"2006","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ebiom.2019.01.042_bb0190","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/bcp.12052","article-title":"The Val158Met polymorphism of the COMT gene is associated with increased pain sensitivity in morphine-treated patients undergoing a painful procedure after cardiac surgery","volume":"75","author":"Ahlers","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ebiom.2019.01.042_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-4-64","article-title":"Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain","volume":"4","author":"Rakvag","year":"2008","journal-title":"Mol Pain"},{"issue":"5","key":"10.1016\/j.ebiom.2019.01.042_bb0200","first-page":"1393","article-title":"Expression changes in arrestin beta 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients","volume":"27","author":"Matsuoka","year":"2012","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2019.01.042_bb0205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/FTD.0000000000000301","article-title":"Genetic predisposition to poor opioid response in preterm infants: impact of KCNJ6 and COMT polymorphisms on pain relief after endotracheal intubation","volume":"38","author":"Elens","year":"2016","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.1016\/j.ebiom.2019.01.042_bb0210","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2217\/pgs.14.100","article-title":"Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype","volume":"15","author":"Matic","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"5610","key":"10.1016\/j.ebiom.2019.01.042_bb0215","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1078546","article-title":"COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor","volume":"299","author":"Zubieta","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2019.01.042_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neuroimage.2005.05.030","article-title":"COMT Val108\/158Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression","volume":"28","author":"Berthele","year":"2005","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.ebiom.2019.01.042_bb0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pain.2012.12.006","article-title":"Does neonatal morphine use affect neuropsychological outcomes at 8 to 9 years of age?","volume":"154","author":"de Graaf","year":"2013","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ebiom.2019.01.042_bb0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/icd.691","article-title":"Developmental changes in the relations between inhibitory control and externalizing problems during early childhood","volume":"20","author":"Utendale","year":"2011","journal-title":"Infant Child Develop"},{"issue":"7","key":"10.1016\/j.ebiom.2019.01.042_bb0235","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1601-183X.2007.00313.x","article-title":"COMT Val(158)Met and 5HTTLPR functional loci interact to predict persistence of anxiety across adolescence: results from the Victorian Adolescent Health Cohort Study","volume":"6","author":"Olsson","year":"2007","journal-title":"Genes Brain Behav"},{"issue":"1\u20133","key":"10.1016\/j.ebiom.2019.01.042_bb0240","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jad.2010.08.009","article-title":"The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study","volume":"129","author":"Aberg","year":"2011","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.ebiom.2019.01.042_bb0245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10862-009-9174-9","article-title":"Concurrent validity of the child behavior checklist DSM-oriented scales: correspondence with DSM diagnoses and comparison to syndrome scales","volume":"32","author":"Ebesutani","year":"2010","journal-title":"J Psychopathol Behav Assess"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:47:13Z","timestamp":1562600833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419300490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":49,"alternative-id":["S2352396419300490"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.01.042","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphine biotransformation genes and neonatal clinical factors predicted behaviour problems in very preterm children at 18\u202fmonths","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}